G. Smith

1.1k total citations
52 papers, 873 citations indexed

About

G. Smith is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, G. Smith has authored 52 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in G. Smith's work include Crystal structures of chemical compounds (6 papers), Statistical Methods in Clinical Trials (4 papers) and Crystallography and molecular interactions (4 papers). G. Smith is often cited by papers focused on Crystal structures of chemical compounds (6 papers), Statistical Methods in Clinical Trials (4 papers) and Crystallography and molecular interactions (4 papers). G. Smith collaborates with scholars based in United States, United Kingdom and Australia. G. Smith's co-authors include Daniel J. Knauer, Howard M. Temin, H. W. Whitlock, Mahshid Mehdipour, Mohsen Sharifi, R. Curtis Bay, Fred Wagner, S. Percy Ivy, Pamela Jo Harris and Lixin Song and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Clinical Oncology.

In The Last Decade

G. Smith

48 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Smith United States 14 299 245 133 116 98 52 873
Elizabeth Higgins United States 16 872 2.9× 36 0.1× 145 1.1× 165 1.4× 108 1.1× 34 1.4k
Chitra Krishnamurti United States 18 180 0.6× 34 0.1× 120 0.9× 151 1.3× 284 2.9× 39 1.1k
J. Škoda Czechia 24 679 2.3× 20 0.1× 88 0.7× 200 1.7× 254 2.6× 137 2.1k
Mark Anderson United States 24 374 1.3× 42 0.2× 996 7.5× 422 3.6× 102 1.0× 101 2.1k
K. Christiansen Denmark 18 537 1.8× 32 0.1× 198 1.5× 52 0.4× 168 1.7× 34 1.3k
Ljubica Glavaš‐Obrovac Croatia 19 352 1.2× 91 0.4× 36 0.3× 364 3.1× 137 1.4× 80 1.1k
G Mangiarotti Italy 16 495 1.7× 79 0.3× 50 0.4× 18 0.2× 29 0.3× 35 796
Russell M. Jones United Kingdom 18 214 0.7× 22 0.1× 264 2.0× 35 0.3× 46 0.5× 44 1.2k
Stefania Angela Di Fusco Italy 15 195 0.7× 60 0.2× 150 1.1× 48 0.4× 23 0.2× 108 928
Patricia A. McIntyre United States 19 203 0.7× 33 0.1× 193 1.5× 24 0.2× 50 0.5× 41 1000

Countries citing papers authored by G. Smith

Since Specialization
Citations

This map shows the geographic impact of G. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Smith more than expected).

Fields of papers citing papers by G. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Smith. The network helps show where G. Smith may publish in the future.

Co-authorship network of co-authors of G. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of G. Smith. A scholar is included among the top collaborators of G. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Smith. G. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Creeth, Jonathan E., et al.. (2024). Remineralisation of enamel erosive lesions by daily-use fluoride treatments: network meta-analysis of an in situ study set. Clinical Oral Investigations. 29(1). 28–28. 2 indexed citations
2.
Li, Rui, Wenjie Yang, Roberta Grimaldi, et al.. (2024). Efficacy of a stannous fluoride dentifrice for relieving dentinal hypersensitivity in Chinese population: an 8-week randomized clinical trial. Clinical Oral Investigations. 28(4). 230–230. 4 indexed citations
3.
Moore, Curtis E., et al.. (2021). Crystal structure of 2,2′-{[(2-nitrobenzyl)azanediyl]bis(propane-3,1-diyl)}bis[1H-isoindole-1,3(2H)-dione]. Acta Crystallographica Section E Crystallographic Communications. 77(2). 83–85. 1 indexed citations
4.
Mooney, Margaret, Matthew Boron, Andrea Denicoff, et al.. (2021). NCI’s national treatment trial networks: Experience and adaptations during COVID-19.. Journal of Clinical Oncology. 39(15_suppl). 1562–1562.
5.
Kunos, Charles A., Jacek Capala, Shanda Finnigan, G. Smith, & Susan Percy Ivy. (2019). Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers. Frontiers in Oncology. 9. 180–180. 5 indexed citations
6.
Powell, Adam C., et al.. (2018). Modification and Reinitiation of Lower Back Imaging Orders After Evidence-Based Collaborative Consultation. Academic Radiology. 26(11). 1450–1456. 2 indexed citations
7.
Mansfield, Aaron S., et al.. (2016). The Effect of Hepatic Impairment on Outcomes in Phase I Clinical Trials in Cancer Subjects. Clinical Cancer Research. 22(22). 5472–5479. 21 indexed citations
8.
Eaton, Anne, Alexia Iasonos, Mrinal M. Gounder, et al.. (2015). Toxicity Attribution in Phase I Trials: Evaluating the Effect of Dose on the Frequency of Related and Unrelated Toxicities. Clinical Cancer Research. 22(3). 553–559. 11 indexed citations
9.
Mansfield, Aaron S., et al.. (2015). Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials. Thrombosis Research. 136(6). 1169–1173. 2 indexed citations
10.
Harris, Pamela Jo, Sally Hunsberger, Amélie Deleporte, et al.. (2014). The Role of Age on Dose-Limiting Toxicities in Phase I Dose-Escalation Trials. Clinical Cancer Research. 20(18). 4768–4775. 6 indexed citations
11.
Luke, Jason J., Larry Rubinstein, G. Smith, S. Percy Ivy, & Pamela Jo Harris. (2013). Similar efficacy for phase I trials in comparison with DTIC for advanced malignant melanoma. Melanoma Research. 23(2). 152–158. 2 indexed citations
12.
Sharifi, Mohsen, et al.. (2010). Endovenous therapy for deep venous thrombosis: The TORPEDO trial. Catheterization and Cardiovascular Interventions. 76(3). 316–325. 92 indexed citations
13.
Ahmed, Nasar Uddin, et al.. (2008). Are Women With Functional Limitations at High Risk of Underutilization of Mammography Screening?. Women s Health Issues. 19(1). 79–87. 20 indexed citations
14.
Smith, G., Douglas R. Powell, Masood A. Khan, & Richard W. Taylor. (2007). Three related benzoannelated diazapolyether macrocycles: effects of macrocycle ring size and position of benzo groups on hydrogen bonding of the amine H atoms. Acta Crystallographica Section C Crystal Structure Communications. 63(7). o378–o381.
15.
Smith, G., et al.. (2006). 1H and 13C NMR assignments and X‐ray structures for three monocyclic benzoannelated dilactam polyethers. Magnetic Resonance in Chemistry. 44(9). 901–904. 1 indexed citations
16.
Sweeney, Corinne R., et al.. (2000). Effect of daily floor treatment with sodium bisulfate on the fly population of horse stalls. American Journal of Veterinary Research. 61(8). 910–913. 11 indexed citations
17.
Veomett, George E., et al.. (1989). Heterogeneity of insulin-like growth factor binding proteins in swine. Molecular and Cellular Endocrinology. 65(1-2). 49–57. 10 indexed citations
18.
Smith, G., et al.. (1982). Effect of a nutritional supplement containing N, N-Dimethylglycine (DMG) on the racing standardbred [Horses].. Equine practice. 7 indexed citations
19.
Knauer, Daniel J., Fred Wagner, & G. Smith. (1981). Purification and characterization of multiplication‐stimulating activity (MSA) carrier protein. PubMed. 15(2). 177–191. 38 indexed citations
20.
Smith, G. & H. W. Whitlock. (1966). -1-oxocrinane. Tetrahedron Letters. 7(24). 2711–2716. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Higgins Breakdown of academic impact, for papers by Chitra Krishnamurti Breakdown of academic impact, for papers by J. Škoda Breakdown of academic impact, for papers by Mark Anderson Breakdown of academic impact, for papers by K. Christiansen Breakdown of academic impact, for papers by Ljubica Glavaš‐Obrovac Breakdown of academic impact, for papers by G Mangiarotti Breakdown of academic impact, for papers by Russell M. Jones Breakdown of academic impact, for papers by Stefania Angela Di Fusco Breakdown of academic impact, for papers by Patricia A. McIntyre
Rankless by CCL
2026